Welcome to our dedicated page for WW International news (Ticker: WW), a resource for investors and traders seeking the latest updates and insights on WW International stock.
WW International, Inc. (NASDAQ: WW), widely known as WeightWatchers, is a renowned leader in the health and wellness industry. The company is dedicated to helping individuals achieve their weight loss goals and sustain a healthier lifestyle through scientifically-backed programs. With a strong focus on behavior change and weight management, WW offers a comprehensive suite of solutions, including in-person workshops, digital tools, and personalized coaching.
WW’s digital platform features an array of tools such as food, water, and activity trackers, along with content on behavioral techniques to build healthy habits. Members also have access to 24/7 expert chat support and over 700 meeting locations across the country, ensuring they receive the guidance needed to stay on track. For those who medically qualify, WW provides access to clinicians who can prescribe weight management medications.
Recent achievements include the launch of the WeightWatchers GLP-1 Program, developed by a team of obesity specialists, clinicians, behavior-change scientists, dietitians, and fitness experts. This program supports members on GLP-1 medications by helping them build and maintain healthy habits while ensuring adequate nutrition and hydration. The WeightWatchers Clinic, now integrated within the WeightWatchers App, offers seamless access to clinical interventions for eligible members in the U.S.
WW generates the majority of its revenue from subscription services, with North America being the primary market. The company's diverse program offerings, such as the Points Program and the Diabetes Program, cater to various needs, ensuring personalized support for all members. WeightWatchers also collaborates with businesses through WeightWatchers for Business, providing employers and health plans with behavior change programs and clinical care access.
WW International continues to focus on expanding its services and enhancing member experiences, guided by a commitment to improve the global health landscape. The company’s proven, science-based approach has inspired millions over the past six decades, solidifying its position as a trusted partner in weight health management.
WeightWatchers (WW) has launched a next-generation program featuring advanced AI-powered features and expanded nutrition support. The program introduces insurance-covered access to registered dietitians, AI-powered food scanning and recipe analysis tools, and over 150 new ZeroPoint® foods. Key features include personalized nutrition counseling, macro-nutrient tracking, and seamless Points® calculation through photo recognition.
The program complements WW's recent expansion into clinical solutions, including access to weight-loss medications. Studies show members using the Points Program alongside medications achieve 56% more weight loss than those using medications alone. The company reports that members experience a 20% improvement in quality of life with their enhanced model of care.
WW International (NASDAQ: WW) has appointed Felicia DellaFortuna as Chief Financial Officer, effective January 1, 2025, replacing Heather Stark who will depart on December 27, 2024. DellaFortuna brings significant financial leadership experience, having previously served as CFO at Enthusiast Gaming and BuzzFeed, where she drove operational efficiency and profitability. At BuzzFeed, she led key acquisitions including Complex Networks and HuffPost, while diversifying revenue streams. The appointment comes during what the company describes as a critical transformation period as it adapts to rapidly evolving industry conditions.
WW International reported Q3 2024 results with revenues of $192.9 million, down 10.2% year-over-year. The company posted an operating loss of $39.0 million compared to operating income of $30.6 million in the prior year. End of Period Subscribers decreased 8.8% to 3.7 million. Clinical Subscribers grew 71.5% to 78,000. Adjusted gross margin improved to 69.1%. The company recorded non-cash impairment charges of $57.0 million for franchise rights. WW reiterated its full year 2024 guidance, expecting year-end subscribers of at least 3.1 million and revenue of at least $770.0 million.
WW International (NASDAQ: WW) has announced it will release its third quarter 2024 financial results before market open on Wednesday, November 6, 2024. The company will host a conference call at 8:30 a.m. ET on the same day, featuring Interim President and CEO Tara Comonte and CFO Heather Stark, who will discuss the results and address questions from investors. A live webcast will be available on corporate.ww.com, along with supplemental investor materials, and will remain accessible for approximately 90 days.
WeightWatchers (NASDAQ: WW) has announced the addition of compounded semaglutide to its weight management program, starting at $129. This expansion aims to enhance accessibility and affordability of weight loss medications amid ongoing shortages of branded GLP-1 drugs. The company's offering combines clinical interventions with behavioral support, including access to board-certified clinicians, registered dietitians, and the WeightWatchers community.
Key points:
- WeightWatchers partnered with an FDA-registered 503B facility to ensure quality and safety
- The company conducted nearly 3 million stock checks, finding GLP-1 medications in stock only 4.5% of the time
- 45% of eligible WeightWatchers Clinic members were denied insurance coverage for GLP-1 medications
- Members using GLP-1 medications with the Points® Program lose 11% more weight than those using medications alone
- Compounded semaglutide will be available to eligible members within 1-3 business days
WeightWatchers (NASDAQ: WW) announced a significant leadership change on Sept. 27, 2024. Tara Comonte, an independent board member, has been appointed as Interim Chief Executive Officer, succeeding Sima Sistani, who is stepping down from her roles as CEO and board member.
During her tenure, Sistani led the company's transformation into a modern digital health organization and expanded its portfolio with the acquisition of Sequence (now WeightWatchers Clinic). Comonte, with her extensive executive leadership experience, is expected to guide the company's transformation, sharpen its strategic focus, and evolve its offerings to drive growth.
The company reaffirmed its full-year 2024 guidance for End of Period Subscribers, Revenue, Adjusted Operating Income, and Adjusted EBITDAS. The WeightWatchers Board of Directors has been reduced from nine to eight members following this transition.
WeightWatchers (NASDAQ: WW) has announced two strategic leadership appointments to drive growth and community engagement. Scott Honken joins as Chief Commercial Officer, overseeing B2B growth, operations, partnerships, and licensing. Phillip Picardi becomes Chief Impact Officer, focusing on building communities and scaling the company's impact work.
Honken, formerly at Calibrate, brings experience from Rightway and Livongo in forming multimillion-dollar partnerships. Picardi, previously Chief Strategy Officer at the Los Angeles LGBT Center, will lead brand marketing, communications, social impact, and employee experience teams.
These appointments align with WeightWatchers' goal to expand access to equitable care and redefine community engagement across all stakeholders, including employers, payers, and health plans.
WW International, Inc. (NASDAQ: WW) announced its Q2 2024 financial results. The company reported revenues of $202.1 million, down 10.9% YoY, with a gross margin of 67.9%. Operating income rose 36.5% to $35.9 million, while adjusted operating income increased 12% to $37.9 million. However, net income dropped 54.2% to $23.3 million, and EPS fell 54.9% to $0.29. End of period subscribers declined 6.1%, with Digital subscribers and Workshops + Digital subscribers decreasing by 4.2% and 21.4%, respectively. The company launched a 2024 restructuring plan to save $100 million annually through operational optimization.
For 2024, WW expects revenues of at least $770 million and adjusted operating income of at least $100 million.
WW International, Inc. (NASDAQ: WW), also known as WeightWatchers, has announced its upcoming second quarter 2024 earnings release and conference call. The company will disclose its Q2 2024 results before the market opens on Thursday, August 1, 2024. Following this, WeightWatchers will host a conference call at 8:30 a.m. ET on the same day.
During the call, CEO Sima Sistani and CFO Heather Stark will discuss the quarterly results and address questions from investors. The event will be accessible via a live webcast on the company's corporate website, where supplemental investor materials will also be available. A replay of the webcast will remain accessible for approximately 90 days after the event.
WW International, Inc. announced its Q1 2024 results, with 4.0 million subscribers and $206.5 million in revenues. The company reported a gross margin of 66.7%, operating loss of $269.3 million due to non-cash intangible impairment charges, and provided full-year guidance. End of period subscribers were down 0.4% year-over-year, while digital subscribers increased by 0.7%. Gross profit was $137.8 million, with adjusted gross profit at $140.3 million. Operating loss was $269.3 million but adjusted to $5.6 million. Net loss was $347.9 million, and the company had a cash balance of $66.6 million as of March 30, 2024.
FAQ
What is the current stock price of WW International (WW)?
What is the market cap of WW International (WW)?
What does WW International, Inc. do?
What is the WeightWatchers GLP-1 Program?
How does WW generate most of its revenue?
What digital tools does WeightWatchers provide?
Where does WW International, Inc. generate key revenue?
What are some of the recent achievements of WW International?
What personalized support does WeightWatchers offer?
How does WeightWatchers support businesses?
What is the mission of WW International?
How long has WW International been in the health and wellness industry?
